Bakul Patel is the director of the FDA's Digital Health Center of Excellence. In this interview, he shares his perspective on approving AI systems. He discusses how the FDA is evolving to keep up with the medical AI market, and he addresses key ethical concerns such as equity and access.
Pranav and Adriel first give an overview on the FDA's premarket pathways for medical devices. The interview with Bakul starts at 8:56. If you like what you hear, let a friend know, subscribe wherever you get your podcasts, and connect with us on Twitter @AIHealthPodcast.
